Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 301

1.

Nesting doctoral students in collaborative North-South partnerships for health systems research.

Loukanova S, Prytherch H, Blank A, Duysburgh E, Tomson G, Gustafsson LL, Sié A, Williams J, Leshabari M, Haefeli WE, Sauerborn R, Fonn S.

Glob Health Action. 2014 Jul 15;7:24070. doi: 10.3402/gha.v7.24070. eCollection 2014.

PMID:
25030216
[PubMed - in process]
Free PMC Article
2.

A systematic review of medication administration errors with transdermal patches.

Lampert A, Seiberth J, Haefeli WE, Seidling HM.

Expert Opin Drug Saf. 2014 Aug;13(8):1101-14. doi: 10.1517/14740338.2014.926888. Epub 2014 Jun 12.

PMID:
24921682
[PubMed - in process]
3.

Memorandum on the Use of Information Technology to Improve Medication Safety.

Ammenwerth E, Aly AF, Bürkle T, Christ P, Dormann H, Friesdorf W, Haas C, Haefeli WE, Jeske M, Kaltschmidt J, Menges K, Möller H, Neubert A, Rascher W, Reichert H, Schuler J, Schreier G, Schulz S, Seidling HM, Stühlinger W, Criegee-Rieck M.

Methods Inf Med. 2014 Jun 6;53(5). [Epub ahead of print]

PMID:
24902537
[PubMed - as supplied by publisher]
4.

A prospective three-step intervention study to prevent medication errors in drug handling in paediatric care.

Niemann D, Bertsche A, Meyrath D, Koepf ED, Traiser C, Seebald K, Schmitt CP, Hoffmann GF, Haefeli WE, Bertsche T.

J Clin Nurs. 2014 Jun 3. doi: 10.1111/jocn.12592. [Epub ahead of print]

PMID:
24890332
[PubMed - as supplied by publisher]
5.

Substantially increased sildenafil bioavailability after sublingual administration in children with congenital heart disease: two case reports.

Carls A, Winter J, Enderle Y, Burhenne J, Gorenflo M, Haefeli WE.

J Med Case Rep. 2014 May 30;8:171. doi: 10.1186/1752-1947-8-171.

PMID:
24885923
[PubMed - in process]
Free PMC Article
6.

[Good prescription practice for out-patients-quality requirements of prescriptions in Germany].

Faller CK, Seidling HM, Haefeli WE.

Ther Umsch. 2014 Jun;71(6):317-23. doi: 10.1024/0040-5930/a000519. German.

PMID:
24867346
[PubMed - in process]
7.

[Good prescribing practice].

Seidling HM, Haefeli WE.

Ther Umsch. 2014 Jun;71(6):313-6. doi: 10.1024/0040-5930/a000518. German.

PMID:
24867345
[PubMed - in process]
8.

Stability of the proteasome inhibitor bortezomib in cell based assays determined by ultra-high performance liquid chromatography coupled to tandem mass spectrometry.

Clemens J, Longo M, Seckinger A, Hose D, Haefeli WE, Weiss J, Burhenne J.

J Chromatogr A. 2014 Jun 6;1345:128-38. doi: 10.1016/j.chroma.2014.04.024. Epub 2014 Apr 16.

PMID:
24780258
[PubMed - in process]
9.

Indirect evidence for proton pump inhibitor failure in patients taking them independent of meals.

Freigofas J, Haefeli WE, Schöttker B, Brenner H, Quinzler R.

Pharmacoepidemiol Drug Saf. 2014 Jul;23(7):768-72. doi: 10.1002/pds.3620. Epub 2014 Apr 10.

PMID:
24723311
[PubMed - in process]
10.

[Use and potential risks of over-the-counter analgesics].

Freytag A, Quinzler R, Freitag M, Bickel H, Fuchs A, Hansen H, Hoefels S, König HH, Mergenthal K, Riedel-Heller SG, Schön G, Weyerer S, Wegscheider K, Scherer M, van den Bussche H, Haefeli WE, Gensichen J.

Schmerz. 2014 Apr;28(2):175-82. doi: 10.1007/s00482-014-1415-5. German.

PMID:
24718747
[PubMed - in process]
11.

Pharmacokinetic interaction profile of riociguat, a new soluble guanylate cyclase stimulator, in vitro.

Rickert V, Haefeli WE, Weiss J.

Pulm Pharmacol Ther. 2014 Aug;28(2):130-7. doi: 10.1016/j.pupt.2014.02.004. Epub 2014 Mar 21.

PMID:
24657506
[PubMed - in process]
12.

Quantification of vorinostat and its main metabolites in plasma and intracellular vorinostat in PBMCs by liquid chromatography coupled to tandem mass spectrometry and its relation to histone deacetylase activity in human blood.

Liu L, Detering JC, Milde T, Haefeli WE, Witt O, Burhenne J.

J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Aug 1;964:212-21. doi: 10.1016/j.jchromb.2014.02.014. Epub 2014 Feb 18.

PMID:
24636840
[PubMed - in process]
13.

Health care costs in the elderly in Germany: an analysis applying Andersen's behavioral model of health care utilization.

Heider D, Matschinger H, Müller H, Saum KU, Quinzler R, Haefeli WE, Wild B, Lehnert T, Brenner H, König HH.

BMC Health Serv Res. 2014 Feb 14;14:71. doi: 10.1186/1472-6963-14-71.

PMID:
24524754
[PubMed - in process]
Free PMC Article
14.

Response to "can CYP3A activity be evaluated for drug interaction using a nanogram dose of probe drug?": evaluation of CYP3A activity with microdoses of midazolam.

Hohmann N, Halama B, Siller N, Mikus G, Haefeli WE.

Clin Pharmacol Ther. 2014 May;95(5):490-1. doi: 10.1038/clpt.2014.28. Epub 2014 Feb 6. No abstract available.

PMID:
24503628
[PubMed - indexed for MEDLINE]
15.

What, if all alerts were specific - estimating the potential impact on drug interaction alert burden.

Seidling HM, Klein U, Schaier M, Czock D, Theile D, Pruszydlo MG, Kaltschmidt J, Mikus G, Haefeli WE.

Int J Med Inform. 2014 Apr;83(4):285-91. doi: 10.1016/j.ijmedinf.2013.12.006. Epub 2014 Jan 13.

PMID:
24484781
[PubMed - in process]
16.

Influence of St. John's wort on the steady-state pharmacokinetics and metabolism of bosentan.

Markert C, Ngui P, Hellwig R, Wirsching T, Kastner IM, Riedel KD, Burhenne J, Weiss J, Mikus G, Haefeli WE.

Int J Clin Pharmacol Ther. 2014 Apr;52(4):328-36. doi: 10.5414/CP202048.

PMID:
24472406
[PubMed - indexed for MEDLINE]
17.

Inappropriate crushing information on ward lists: cytotoxic drugs, capsules, and modified release formulations are gravely neglected.

Lohmann K, Ferber J, Send AF, Haefeli WE, Seidling HM.

Eur J Clin Pharmacol. 2014 May;70(5):565-73. doi: 10.1007/s00228-013-1638-x. Epub 2014 Jan 28.

PMID:
24468805
[PubMed - in process]
18.

Inequalities in out-of-pocket payments for health care services among elderly Germans--results of a population-based cross-sectional study.

Bock JO, Matschinger H, Brenner H, Wild B, Haefeli WE, Quinzler R, Saum KU, Heider D, König HH.

Int J Equity Health. 2014 Jan 8;13(1):3. doi: 10.1186/1475-9276-13-3.

PMID:
24397544
[PubMed - in process]
Free PMC Article
19.

Drug interactions with phytotherapeutics in oncology.

Haefeli WE, Carls A.

Expert Opin Drug Metab Toxicol. 2014 Mar;10(3):359-77. doi: 10.1517/17425255.2014.873786. Epub 2014 Jan 6.

PMID:
24387348
[PubMed - in process]
20.

Telaprevir is a substrate and moderate inhibitor of P-glycoprotein, a strong inductor of ABCG2, but not an activator of PXR in vitro.

Weiss J, Becker JP, Haefeli WE.

Int J Antimicrob Agents. 2014 Feb;43(2):184-8. doi: 10.1016/j.ijantimicag.2013.10.003. Epub 2013 Nov 5.

PMID:
24332840
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk